Answers are grounded in this paper and cite their sources.
Cellular model reveals p75NTR extracellular domain’s role in α-synuclein aggregation and cell death, suggesting new therapeutic targets.
Objective While the p75 neurotrophin receptor (p75NTR) is critically implicated in the aggregation of α-synuclein (α-syn), a defining pathological hallmark of Parkinson’s disease, the distinct functional contributions of its structural domains remain largely unresolved. Methods To investigate this, we employed a rotenone-induced cellular Parkinson’s disease model utilizing SH-SY5Y neuroblastoma cells transfected with plasmids encoding specific p75NTR truncation mutants. Results Overexpression of a mutant representing the p75NTR extracellular domain (HA-p75Δ151, lacking residues 277–427) significantly exacerbated both α-syn expression levels and its aggregation phenotype. This effect is potentially attributable to the aberrant activation of caspase-1. Conversely, unlike full-length p75NTR which enhanced α-syn ubiquitination, the HA-p75Δ151 truncation failed to modulate ubiquitination dynamics. Furthermore, expression of this extracellular domain fragment induced cell cycle dysregulation and promoted cell death. Conclusion These findings delineate the p75NTR extracellular domain-induced α-syn proteotoxic stress. This domain-specific mechanism advances our understanding of Parkinson’s disease pathogenesis and highlights the therapeutic potential of targeting specific p75NTR domains.
No takes yet. Share an insight, caveat, or question.
You et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: